Open Joint Stock Company Vimpel-communications (VIP) +1.05

Trade VIP
NOW!
Last Trade:17.82Short Ratio:0.80
Last Trade Time:4:01pmDay Range:17.00 - 17.85
Ask:Year Range:6.25 - 22.55
Bid:One Year Target:26.55
Open:17.03Exchange:NYSE
Volume:14728432EBITDA:4.309B
Prev. Close:16.77Market Cap:18.064B
50 Day Moving:18.37Div Yield:1.94
200 day moving:18.9009PE:762.27

Related RealMoney articles from TheStreet.com

Cramer's 'Mad Money' Recap: Add Some Speculative Stocks to Your Portfolio (Update 3)
'Mad Money Lightning Round': No on Vimpel
'Fast Money' Recap: Weak Jobs Report?

We Pick Penny Stocks Alerts on Friday`s Top 5 Volatile Winners

Posted on 03/20/10 at 3:00am
(EMAILWIRE.COM, March 20, 2010 ) Dallas, TX - Following were among the companies whose shares were actively traded in Friday's session.
Click here to read the rest of the article

Communications Stocks Rallied are Q, T, VZ, VIP, CTEL, LEAP

Posted on 03/19/10 at 3:00am
(EMAILWIRE.COM, March 19, 2010 ) Dallas, Tx - Qwest Communications International Inc. (NYSE:Q) advanced 2.01% at $5.07. The stock today also touched a new 52 week high at $5.12. So far in the last six months trade the stock went up over 44%.
Click here to read the rest of the article

Thursday`s Top 5 Active Stock Losers (SIRI, ETFC, VIP, CHK, MI)

Posted on 03/19/10 at 3:00am
(EMAILWIRE.COM, March 19, 2010 ) Dallas, Tx - Following were among the companies whose shares were actively traded in Thursday's session.
Click here to read the rest of the article

VimpelCom Announces Fourth Quarter and Full-Year 2009 Financial and Operating Results

Posted on 03/18/10 at 7:06am
VimpelCom Announces Fourth Quarter and Full-Year 2009 Financial and Operating Results PR Newswire MOSCOW and NEW YORK, March 18
Click here to read the rest of the article

VimpelCom to Release Fourth Quarter and Annual 2009 Financial and Operating Results on Thursday, March 18, 2010

Posted on 03/17/10 at 1:06pm
VimpelCom to Release Fourth Quarter and Annual 2009 Financial and Operating Results on Thursday, March 18, 2010 Please be advised that due to time change the conference call will be held on Thursday, March 18, 2010, at 11:30 a.m. U.S. EDT (6:30 p.m.
Click here to read the rest of the article

Fast Money Lightening Round: Jim Trounces VIP, VMC, AVP; Favors CL, PL Instead

Posted on 03/17/10 at 8:17am
In his “Mad Money Lightening Round,” Jim Cramer warned investors to not buy Vulcan Materials (NYSE: VMC). VMC gained 2.22% yesterday. Jim also thinks that it is time to get out of VimpelCom (NYSE: VIP). VIP added 1.36% in yesterday’s trading.
Click here to read the rest of the article
Posted in

SmarTrend's Candlestick Scanner Detects Bearish Harami Pattern for Vimpel-Communications (VIP)

Posted on 03/12/10 at 8:33am
SmarTrend's candlestick pattern scanner has detected a bearish harami candle pattern for shares of Vimpel-Communications (NYSE: VIP). Yesterday's real body is within the previous day's body and may imply that traders and investors believe that the recent uptrend may be nearing an end.
Click here to read the rest of the article

VimpelCom To Release Fourth Quarter and Annual 2009 Financial and Operating Results on Thursday, March 18, 2010

Posted on 03/11/10 at 9:27am
VimpelCom To Release Fourth Quarter and Annual 2009 Financial and Operating Results on Thursday, March 18, 2010 PR Newswire MOSCOW and NEW YORK, March 11
Click here to read the rest of the article

Wednesday`s Most Active Gainers (Ford, VLO, RSH, VIP, AEO, STI, SIRI, MU, Sprint, ALU, HLX)

Posted on 03/11/10 at 4:00am
(EMAILWIRE.COM, March 11, 2010 ) Dallas, Tx - U.S. stocks closed almost flat Wednesday. The Dow Jones Industrial Average rose 2.95 points to 10567.33 the Standard & Poor's 500 rose 5.17 points to 1145.61 and the Nasdaq Composite Index rose 18.27 points to 2358.95.
Click here to read the rest of the article

Tuesday`s Most Active Stock Movers (CTIC, BC, IMAX, VIP, CMA, DRYS, SIRI)

Posted on 03/10/10 at 4:00am
(EMAILWIRE.COM, March 10, 2010 ) Dallas , Tx - Cell Therapeutics, Inc. (NASDAQ:CTIC) fell 6.09% to $1.08 on 32.50 million shares after the company said U.S. health regulators approved the facility to manufacture its experimental cancer drug currently under review.
Click here to read the rest of the article